SECA | Swiss Private Equity & Corporate Finance Association

eNewsletter no. 432 Dear Reader 06 March 2015

Slowly, I get nervous. At a Corporate Venture Capital conference in SECA California, a friend of mine challenged the head of Intel Capital on a panel about the rise and risk of hedge funds and mutual funds in Venture Capital late stage investments, bringing the feel back of dot com times. He Private Equity – Swiss News did not have a good answer, but another guy in the room from CB Insights made some research on the issue. Private Equity – Int. News More and more hedge funds allocate their capital in the VC later Corporate Finance stage market. They jumped into companies including AirBnB, Mergers & Acquisitions Cloudera, Dropbox and Uber among dozens of others. The Management Buyout investment deal trends of five mutual funds – BlackRock, Fidelity Investments, Janus Capital, T. Rowe Price, and Wellington Book of the Week Management – into U.S. VC-backed tech companies over the last Jobs four years seems incredible. Notably, T. Rowe Price increased its private tech deals into venture-backed startups by 2x in 2014. And Agenda after no U.S. tech deals in 2013, Wellington Management jumped Editor into 12 deals including a $70.9M investment into real estate tech platform Redfin as well as a $40M round into Boston-based cybersecurity company Veracode, which recently disclosed IPO plans, reports CB Insights. Toolbox A mix of traditional VC money coupled with corporate VCs, hedge Print Newsletter funds, private equity investors and even sovereign wealth funds Send Newsletter to a Friend lifted 2014 funding levels to the highs seen during the dot com Download as PDF boom. With VCs like Benchmark’s Bill Gurley calling out ‘FOMO’ in the frothy late-stage market today, will 2015 continue the trend of mutual fund and hedge fund tech startup deal-making?

Have a nice weekend! Maurice Pedergnana

SECA

Young SECA & PCU Get Together Event

Donnerstag, 21. Mai 2015, Blue Monkey Zunftsaal zur Schneidern, Zürich

Geschätzte Young SECA Mitglieder - Young SECA freut sich euch zum 10. Young SECA Get Together einzuladen. Als besonderes Highlight konnte Dani Gutenberg, seines Zeichens General Partner von VI Partners und Business Angel des Jahres 2011, als Speaker gewonnen werden. Bitte beachtet, dass die Platzzahl limitiert ist. Daher gilt first come, first served. Nutzt diese einmalige Chance und meldet euch noch heute für diesen Event im kleinen Rahmen im Herzen von Zürich an.

weitere Informationen und Anmeldung

4. SECA Private Equity Workshop

6.-7. November & 20.-21. November 2015

SECA Private Equity Workshop: Die Assetklasse Private Equity & Private Markets vermittelt in kompakter Form für Praktiker. Ziel des 4. SECA Private Equity Workshops ist es, einen umfassenden Einblick in die Struktur, die Funktionsweise, die Dynamik der Private Markets‐Industrie sowie Handlungsempfehlungen aus der Sicht des Investors zu erhalten, was letztlich wesentlich zum besseren Verständnis der vorhandenen Chancen und Risiken dieser faszinierenden Assetklasse beiträgt.

more information and registration

Venture Capital

Media Monitoring

Venture Capital: Investitionen auf Rekordhöhe

BAND begrüsst BVK-Vorschlag für Venture-Capital Gesetz

Beteiligungskapitalmarkt: German Private Equity Barometer auf Dreijahreshoch

Eine Typologie von VC-Investoren

Mehr Wagnis

Platzierungszahlen 2014: PE und VC

Biotech-Firmen kehren an die Kapitalmärkte zurück

Otto spendiert Startups zweistelligen Millionenbetrag

Wie Afrikas Start-ups auf neuen Wegen zu westlichem Kapital finden

Venionaire ist mit 100 Mio. Euro-Fonds auf Suche... Business Angels Panel veröffentlicht

Neues Joint Venture von Starwood Capital Group und Meliá erwirbt spanische Resorts

So viel wurde 2014 in Deutschland investiert

Investitionen steigen: Niedrigzins treibt VC und PE Investoren an

Angriff auf die Männerbastion Silicon Valley

Venionaire: »Wir sind kleine Leuchttürme«

Digital-Branche wird professionell

Macrolide Pharmaceuticals raises first round funding

On 04/03/15 Macrolide Pharmaceuticals Inc., a Newton, Massachusetts-based novel macrolide antibiotics developer, announced that it has raised USD 22 million in a first (Series A) round of funding led by Novartis Venture Funds (the venture arm of Novartis AG), Gurnet Point Capital Ltd, Roche Holding AG's Roche Venture Fund (Ventures), and SR One Ltd (SROne). Source: Zepyhr

Merganser Biotech raises first round funding

On 19/02/15 Merganser Biotech Inc., a Newtown Square, Pennsylvania-based peptidyl therapeutics developer, announced that it has raised USD 28 million in a first (Series A) round of funding led by Novartis AG's Novartis Venture Fund, with participation from Frazier Management LLC (Frazier Healthcare), Sutter Hill Ventures, Osage University Partners, and existing investors The Biotechnology Greenhouse Corporation of Southeastern Pennsylvania (BioAdvance) and Stateside Developments. Source: Zepyhr

Vaxin secures funding

On 17/02/15 it was announced that Vaxin Inc., a Gaithersburg, Maryland-based bio-vaccine and other associated biological products developer raised USD 16 million in funding from Novartis Venture Fund, HealthCap AB, Truffle Capital SAS, and Redmont Capital. In addition the company also announced that it has agreed to acquire Immune Targeting Systems (ITS) Ltd. Source: Zepyhr

Sosei acquires Heptares Therapeutics

On 23/02/15 it was announced that Sosei Group Corporation acquired Heptares Therapeutics Ltd, a Welwyn Garden City, UK-based clinical-stage G protein-coupled receptors (GPCR) pharmaceutical products manufacturer from Clarus Ventures LLC, MVM Life Science Partners LLP, Novartis Venture Funds, The Stanley Medical Research Institute and Takeda Ventures Inc. The consideration was up to USD 400 million and comprises of an initial cash payment of USD 180 million with up to a further USD 220 million to be paid in an earn-out payment conditional upon Heptares' successful progression of its pipeline and platform. The transaction represents an exit for VC investors. Source: Zepyhr

PZ Cormay sells Orphee stake

On 26/02/15 it was announced that PZ Comay SA has sold a 12 per cent stake in Orphee SA, the Plan-les-Ouates, Switzerland based haematology diagnostic instruments manufacturer, for PLN 2 per share (deal value: 2,228,000 Euro. Source: Zepyhr

Mindcast TV - Folge 5: Software-Entwicklung in Indien

Markus Hegi hat Ende der 90er-Jahre die Schweizerisch-Indische Softwarefirma Colayer gegründet und entwickelt seitdem Software in Indien. Er spricht mit Pascal Kocher über seine Gründerzeit in Indien und worauf man achten sollte, wenn man in Indien Software entwickeln will.

Mindcast TV easySYS receives second round funding from Armada and Redalpine

On 23/02/15 it was announced that easySYS AG, the Rapperswil, Switzerland based business management Software-as-a-Service (SaaS) provider, has received CHF 4.5 million in second round (Series B) financing in a funding round led by Armada Investment Group AG. Redalpine Venture Partners AG also participated. Source: Zephyr

FinLab and Club Deal acquire majority stake in Venturate

On 20/02/15 it was announced that FinLab AG and Club Deal AG have, between them, acquired an 80 per cent stake in Venturate, the Munich, Germany based online crowdfunding platform operator. FinLab holds a 60 per cent stake and Club Deal a 20 per cent stake. Source: Zepyhr

Boldomatic receives seed funding

On 19/02/15 it was announced that Boldomatic SA, the Zurich, Switzerland based online social network operator has received USD 700,000 in seed funding from European business angels and investors. Source: Zepyhr

Helium Rising Stars Fund acquires minority stake in Best of the Best

On 26/02/15 it was announced that ISPartners Investment Solutions AG (Helium Rising Stars Fund) acquired a minority stake in Best of the Best plc, a London, UK-based airport prize competition operator. In the transaction, Helium Rising Stars Fund acquired 275,000 shares in Best of the Best, which values the transaction at GBP 200,750. The shares acquired in the transaction represent a 3.0 per cent stake based on Best of the Best's 9,099,052 shares outstanding. Source: Zepyhr

Jampp raises first round funding

On 25/02/15 Jampp Ltd, a UK-based online mobile app user acquisition and re-engagement platform operator, announced that it has raised USD 7 million in a first (Series A) round of funding by HCP (Geneva) Sarl (Highland Europe), with participation from Endeavor Global Inc. (Endeavor Catalyst), Innova and NXTP Labs SRL. Source: Zephyr

b-to-v invests in Series A rounds of EFFECT Photonics and Webdata Solutions

EFFECT Photonics, the Eindhoven based photonics company, closed its Series A funding to bring its Optical System-on-Chip technology to market to meet the soaring demand for bandwidth in cell towers and between datacenters. The investment round was led by b-to-v, and included the Brabant Development Agency (BOM) as well as Optidob. Dr. Christian Reitberger, member of the b-to-v Circle of Investors, will join the board of the company on behalf of b-to-v. For more information please read more under the link above.

read more easySYS: 4.5 Million Funding Round

Redalpine Capital announced the latest addition to our portfolio: easySYS (Redalpine Capital II) has just closed a CHF 4.5m funding round under the lead of Armada Investment AG and Redalpine.

Prexton Therapeutics raises first round funding

On 24/02/15 Prexton Therapeutics SA, a Plan les Ouates, Switzerland-based central nervous system (CNS) conditions biopharmaceuticals developer, announced that it has raised EUR 8.7 million in a first round of funding which was co-led by Sunstone Capital A/S and Ysios Capital Partners SGECR SA, and included participation from existing investor MS Ventures (the venture arm of Merck KGaA). Source: Zepyhr

Remora Capital achieves its first exit Lausanne, Switzerland, 23 February 2015 – Remora Capital SA, an independent investment company active since 2010 in healthcare, beauty care and nutrition start-ups, completes its first successful exit as PPF group acquires a significant minority stake in Cytune Pharma, an oncoimmunology biotechnology company.

press release

Swisscows Entwicklungsfirma Hulbee mit neuer Such-Software für Unternehmen

Die Swisscows Software Firma Hulbee AG entwickelt die Suchsoftware „Swisscows Enterprise Search“ für mittlere bis grössere Unternehmen, welche alle Betriebssysteme unterstützt. Dank semantischer Suche werden damit auch bei einer unstrukturierten Datenablage die wichtigen Dokumente rasch gefunden.

Die Suche erfolgt unabhängig vom Betriebssystem; sie ist übergreifend und unterstützt alle Betriebssysteme – sei es Microsoft oder Apple. Wie bei der Suchmaschine Swisscows legt die neue Software grössten Wert auf die Datensicherheit.

Hulbee beschäftigt 43 Spezialisten für künstliche Intelligenz. Neben der Suchmaschine Swisscows hat Hulbee das Schweizer Preisvergleichsportal Kauftipp.ch entwickelt, das Konsumenten hilft, die richtige Kaufentscheidung für rund 15 Millionen Produkte zu treffen. Die weiteren Funktionen umfassen eine vollständige Web- und Bildsuche, zudem ist Swisscows kindersicher. Erotik- und Pornoseiten sind nicht auffindbar – damit eignet sich Swisscows besonders auch für Kinder und Jugendliche. Swisscows verzeichnet monatlich 850‘000 Unic User und 4,2 Millionen Page Impressions.

Medienmitteilung

TerraLUX secures funding

On 04/03/15 TerraLUX Inc., a Longmont, Colorado-based light-emitting diode systems manufacturer announced that it has raised USD 11 million in a round of funding. The funding was led by EnerTech Capital Partners LLP and also included Generation Investment Management LLP, Crawley Ventures, Emerald Technology Ventures AG, GC&H Investments LLC and founder Dr Anthony Catalano. Source: Zephyr

Swissport and Ghana Airport Cargo Centre establish joint venture Swissport Ghana

On 26/02/15 it was announced that Swissport Ghana, a joint venture in between Swissport International AG, a Zurich, Switzerland-based airport ground handling services provider and Ghana Airport Cargo Centre Ltd, a Accra, Ghana-based cargo warehousing services provider has started the operations. Each of ther joint venture partners owns a 50 per cent stake. Source: Zepyhr read more

Cancer Drug Once Bought for $7 Million May Now Fetch $18 Billion

An overlooked drug bought by a biotech company for a mere $6.6 million a decade ago could become one of the biggest selling cancer treatments ever. To read the entire article, go to: Link

Mindmaze receives funding from angels

On 04/03/15 it was announced that Mindmaze Holding SA, the Ecublens, Switzerland based neurological recovery technology developer, received USD 8.5 million in development capital from undisclosed angel investors. Source: Zephyr

Private Equity – Swiss News

Baxter's Bioscience Business acquires BioMedInvest I portfolio company SuppreMol GmbH for EUR 200 mio.

BioMedPartners hat mit dem BioMedInvest AG I Fonds im Sommer 2008 im Rahmen der Serie B Finanzierungsrunde als Co-Lead Investor ihr erstes Investment in die Firma getätigt, und die Firma während der ganzen Zeit in strategischen und operativen Belangen unterstützt. Markus Hosang, einer der General Partner von BioMedPartners, war seit 2008 in Beirat der Firma (unter anderem als Vorsitzender der Vergütungsausschusses), und hat eng mit dem Management und dem hochkalibrig besetzten Beirat zusammengearbeitet, um die Firma zum Erfolg zu bringen. Diese Transaktion stellt einen der besten Verkäufe einer privaten Biotechnologie Firma in Europa in der letzten Zeit dar. Sie ist nicht nur eine Validierung der BioMedInvest Strategie, als aktiver Investor innovative Firmen zu finanzieren, zu formen und schlussendlich zum erfolgreichen Exit zu führen, sondern auch ein Beweis für die nach wie vor intakte Attraktivität der Biotechnologie in Europa.

Medienmitteilung

Change of Name: From APEN AG to Spice Private Equity AG

APEN Ltd announces change of the company name to Spice Private Equity Ltd and the election of Mr Fersen Lamas Lambranho as a new board member.

Medienmitteilung ALTIN: Strike price of put options set at USD 64 and timeline of the share buyback

Following the announcement issued by the Company on 20 January 2015, the Board of Directors of ALTIN AG (SIX: ALTN, LSE: AIA) has set the strike price of the put options to be issued as part of its share buyback programme at USD 64. The strike price is set at a 13.6% premium above the closing share price on SIX Swiss Exchange on 23 February 2015. ALTIN's Board of Directors reaffirms its strong commitment to find efficient and sustainable ways to better align the share price of the company with its NAV and hence to reduce the discount in the best interest of all shareholders. If necessary, the Board may decide to further reduce capital through similar share buybacks.

Press Release

Carlyle Group to acquire Palacios: further information disclosed

On 25/02/15 it was announced that Carlyle Group LP will acquire Grupo Empresarial Palacios Alimentacion SA, the Albelda de Iregua, Spain-based pre-cooked foods manufacturer from ProA Capital de Inversiones SGECR SA. No further details were disclosed. On 26/02/15 it was announced that Carlyle Group via the Carlyle Europe Partners IV fund will acquire an approximate 90 per cent stake in the company held by Partners Group AG, Talde Gestion SGECR SA and Talde Gestion SGECR SA. The transaction is expected to be completed by 30/06/15. Source: Zepyhr

CastlePE - 2014 annual report available

Castle Private Equity's 2014 annual report is now available on the Castle Private Equity website at www.castlepe.com.

The key developments are as follows:

The value of net asset value per share and distributions to shareholders increased by 6.3 per cent to USD 15.39 per share or USD 517 million overall.

Uncalled commitments reduced further to USD 75 million at year end, equivalent to 14 per cent of net asset value (2013: 16 per cent).

Castle Private Equity AG returned CHF 91m of capital to shareholders in the year. A further CHF 29 million was used by the company to buy back its own shares for cancellation.

Closing Mitteilung - SCM Strategic Capital Management AG ist nun Teil von Mercer Investments

Mit der Übernahme durch Marsh & McLennan Companies wird SCM nun Teil von Mercer Investments, einem global führenden Anbieter im Bereich von Anlageberatung und -dienstleistungen. SCM wird weiterhin als unabhängiges FINMA und AIFM (letzteres durch die bestehende Verwaltungsgesellschaft in Luxemburg) lizenziertes Unternehmen für bestehende und neue Kunden unabhängige Anlageberatung anbieten. Medienmitteilung

Private Equity – Int. News

Media Monitoring

Private Equity: Billiges Geld lässt Firmenjäger ausschwärmen

"European Private Equity Outlook 2015": Zurückhaltung am Private Equity-Markt steigt ...

Private Equity bringt Banken zurück auf Schiffsmarkt - UniCredit

Private Equity bringt Banken zurück an den Schiffsmarkt

Wagniskapital profitiert nicht vom Private Equity-Boom

LGT erweitert Angebot für asiatische Kunden

Gute Stimmung am Beteiligungskapitalmarkt

Private Equity: Die Rückkehr der Heuschrecke

PwC sieht Aufschwung für Private Equity

Insider berichten: Private-Equity-Firmen wollen sich Bogner krallen

Azelis: Übernahme durch Private-Equity-Gesellschaft Apax

Private-EquityFinanzinvestoren sorgen sich vor der nächsten Krise

Auf Schnäppchenjagd in der Öl-Industrie

Kommentar der FAZ: Private Equity Investoren werden bescheidener

Branche begrüßt neue Anlageverordnung

Investors are driving increased adoption of ESG policies, report finds

Institutional investors are increasingly demanding that private equity firms adopt ESG policies in their investment processes, according to new research conducted by the London Business School’s Coller Institute of Private Equity and supported by Adveq, the private equity investor. The study shows that larger firms are feeling this pressure more acutely with 85% of the larger firms surveyed commenting that pressure from LPs to integrate ESG policies into everyday working practices is intensifying.

press release Report

Corporate Finance

Media Monitoring

EU schürft nach neuen Geldquellen für Unternehmen

China: IPO-Wahn schafft Milliardäre im Dutzend

IPOs: Europa holt weiter auf!

Delivery Hero will definitiv an die Börse, Uber wird zum Konkurrenten

Exklusiv: Rocket-Internet-Beteiligung Delivery Hero: „Wir gehen an die Börse“

Zwei prominente Aktionäre sind bei Sunrise eingestiegen

Sixt prüft IPO seiner Leasingsparte

IPO: Billigflieger Wizz Air startet erfolgreich an der Börse

Chinesische Postbank plant Milliarden-IPO

Douglas-IPO: Börsen-Comeback rückt für Parfümeriekette näher

European Macroeconomic Outlook

A joint white paper by Wellershoff & Partners Ltd and Akina Ltd.

Past the Eurozone crisis

Economic recovery to gain traction

Beyond the business cycle

Akina Newsletter - February 2015

Greenwatt acquires stake in Entegra from Entec

On 19/02/15 it was announced that Group E Greenwatt SA has acquired a 25 per cent stake in Entegra Wasserkraft AG, the St Gallen, Switzerland based Hydroelectric power plant operator, from Entec AG. Source: Zepyhr

PTC Therapeutics explores a sale: Reuters

US-based rare disease drug maker PTC Therapeutics could choose to delist following interest from a number of pharmaceutical companies including Shire and BioMarin, people with knowledge of the matter told Reuters. According to the sources, who asked not to be named as talks are still private, the group has hired a financial advisor to evaluate strategic alternatives. The group raised USD 108.75 million last year as it prepared for the launch of its ataluren product, the first approved medication for Duchenne muscular dystrophy in the European Union. It tapped investors including Credit Suisse and Citigroup for the funds in October. Source: Zepyhr

Mergers & Acquisitions

Alpiq acquires Helion

On 24/02/15 it was announced that Alpiq Holding AG has acquired Helion

Solar AG, the Luterbach, Switzerland based solar panel installation services provider, for an undisclosed consideration. Source: Zephyr

Aryzta acquires Pre Pain

On 24/02/15 it was announced that Aryzta AG has acquired Pre Pain BV, the Oldenzaal, Netherlands-based commercial bakery operator. Gilde Equity Management (GEM) Benelux Partners BV will exit the company. Source: Zepyhr

Global Pharma / Biotech M&A Report 2015

Kurmann Partners presents the 2015 edition of the Global Pharma Biotech M&A Report by IMAP. This year's report features:

Global review: Record-breaking M&A activity in the Pharma / Biotech industry in 2014

Regional trends and deal drivers: USA, Western Europe, CEE, China, Latin America

M&A in Pharma manufacturing: CMO consolidation and disposal of manufacturing sites by Big Pharma

Tax inversions by US Pharma companies: one of the major deal and valuation drivers in the past years

Poster: the molecular structure of the top 30 drugs by sale

Download the full report als PDF

LOGiQ3 and MSG Global Solutions to create joint venture company and to buy a software developer

On 19/02/15 it was reported that LOGiQ3 Corporation, a Toronto, Ontario based life insurance services provider company, and MSG Global Solutions AG, a Regensdorf, Switzerland based IT consulting services provider company, are to form a joint venture company. It was also announced that Tindall Associates Inc., an Orlando Park, Illinois based life reinsurance software developer company, has been acquired by this new joint venture company between LOGiQ3 Corporation and MSG Global Solutions AG. read more

M&A-Seminar am 27.03.2015 in Zürich

Binder Corporate Finance AG führt wiederum das M&A-Seminar «Transaktionserfahrung aus erster Hand» in Zürich durch. Das praxisnahe M&A-Seminar widmet sich den vorrangigen Themen und Fragen bei M&A-Prozessen. Anhand einer integrierten Fallstudie und über konzentrierte Theorieteile werden die wesentlichen Lerninhalte vermittelt. Ausführliche Informationen finden Sie im beiliegenden Flyer.

Sika agrees to acquire BMI Products of Northern California

On 02/03/15 it was announced that Sika AG has agreed to acquire BMI Products of Northern California Inc., a Milpitas, California-based mortar products manufacturer. Source: Zepyhr

TE to buy AdvancedCath

Swiss electronic connectors and components maker TE Connectivity

(Schaffhausen) has agreed to acquire US medical device manufacturer AdvancedCath for USD 190.0 million in cash. Founded in 2001, the target has estimated 2015 revenues of USD 60.0 million. Subject to the usual raft of regulatory approvals, the deal is expected to complete by the end of March 2015. Terrence Curtin, president of the buyer, said: “The acquisition of AdvancedCath expands TE's Medical business and positions us to be a leading provider of connectivity and sensor solutions in the high-growth medical device market. “The combination of TE's connectivity and sensor solutions with AdvancedCath's expertise in the medical device market provides customers with an unmatched set of capabilities and technologies that enable future innovations and medical advances.” TE generated net sales of USD 3.5 billion in the three months ended 26th December 2014, a 4.2 per cent increase on USD 3.3 billion in the first quarter of fiscal 2014. Net income rose 33.7 per cent to USD 472.0 million in Q1 2015 (Q1 2014: USD 353.0 million). Source: Zephyr

Silent Circle aquires blackphone

On 26/02/15 it was announced that Silen Circle has acquired the 50 per cent stake it did not already hold in SGP Technologies SA, the Le Grand-Saconnex, Switzerland based secure VoIP communication services provider which trades as blackphone. The stake was acquired from Geeksphone SL for an undisclosed consideration. Source: Zepyhr

Management Buyout

UET to acquire Albis in an institutional buyout

On 02/03/15 it was announced that UET United Electronic Technology AG is to acquire Albis Technologies AG, the Zurich, Switzerland based terminal equipment manufacturer. The transaction is to be paid for through a EUR 1 million cash payment and the issuance of 1 million new UET shares. Based on the closing share price of EUR 0.7 on 27/02/15 the shares have a value of EUR 700,000 giving an estimated total deal value of EUR 1.7 million. Source: Zepyhr

Book of the Week

Real Estate Asset Management

Das Interesse an direkten und indirekten Immobilieninvestitionen im Inland und Ausland ist bei institutionellen Investoren seit Jahren ungebrochen. Damit einhergehend nehmen die Strukturierung und das Management der Immobilieninvestitionen einen immer wichtigeren Stellenwert ein bzw. die damit verbundene Auswahl, Führung und Steuerung eines internen und/oder externen Asset Managers. Aufbauend auf den Ergebnissen einer Studie zum Real Estate Asset Management in der Schweiz, Deutschland und Österreich werden der derzeitige Stand des Immobilienmanagements analysiert sowie Handlungsempfehlungen abgeleitet. Schwerpunkt der Ausführungen ist eine Gruppierung institutioneller Investoren anhand von verhaltensbasierten Kriterien und die Ableitung von sechs Clustern für Investitionen in und das Management von direkten und indirekten Immobilienanlagen. Das Fachbuch umfasst neben den detaillierten Studienergebnissen ausgewählte Artikel zu verschiedenen Aspekten der Immobilienanlage und richtet sich gleichermaßen an Investoren, Produktanbieter und Wissenschaftler.

Inhaltsverzeichnis weitere Informationen

weitere Informationen und Bestellung

Jobs

Investment Associate

Wineus AG ist eine Finanzboutique mit Sitz in Zürich. Wir begleiten Unternehmer und Unternehmen insbesondere in den Bereichen Investment Advisory, M&A und Finanzierungen. Zudem nehmen wir im Auftrag unserer Kunden Beteiligungen an erfolgversprechenden Unternehmen vor, die wir langfristig und aktiv begleiten, um ihren Wert zu steigern.

Zur Verstärkung unseres Teams suchen wir:

eine(n) erfahrene(n) Investment Associate

Stelleninserat Investment Associate

How to publish a job ad

On this place your Job ad could be published.

If you are interested please send an e-mail with your job ad, the company logo and a short description about the Job and/or the Company to [email protected].

for SECA Members CHF 100.- / 2 Weeks

for Non-Members CHF 200.- / 2 Weeks

Agenda

M&A-Seminar Transaktionserfahrung aus erster Hand

Freitag, 27. März 2015, Radisson Blu Hotel, Zurich Airport

M&A-Transaktionen gehören zu den anspruchsvollsten Herausforderungen der unternehmerischen Tätigkeit. Das Seminar beleuchtet die zentralen Aspekte des gesamten M&A-Prozesses. Anhand einer integrierten Fallstudie, welche Sie wahlweise mit Käufer oder Verkäufer-Fokus absolvieren können, und über konzentrierte Theorieteile werden die wesentlichen Lerninhalte vermittelt.

weitere Informationen

unquote Nordic Private Equity Forum 2015

Tuesday, 5 May 2015, Grand Hôtel, Stockholm

The 11th annual unquote" Nordic Private Equity Forum taking place on the 5th of May in Stockholm, will bring together leading senior private equity professionals to discuss the future landscape of private equity in the Nordic region. Join us for the most renowned and established private equity forum in the Nordic region. It will be a day filled with insightful presentations, discussions and critical networking with the private equity market champions. SECA Member benefit from a discount of 20%. The discount code is VIP:SECA

more information and registration

India Symposium 2015 - Plattform für einen indisch-europäischen Wirtschaftsaustausch

Freitag, 29. Mai 2015, The Dolder Grand, Zürich Der India Symposium-Verein veranstaltet bereits zum 10ten Mal in Folge am Freitag, 29. Mai 2015, im Zürcher The Dolder Grand Hotel das «India Symposium» und bietet dabei Akteuren aus Wirtschaft, Politik, Wissenschaft und Gesellschaft eine Plattform für aktiven Netzwerk- und Erfahrungsaustausch zum Thema Indien.

Programm

weitere Informationen und Anmeldung

Upcoming SECA Events - save the date

Annual General Meeting 06.05.15, Au Premier, Zürich

14th Swiss Private Equity and Corporate Finance Conference, 08.07.15, SIX, Convention Point, Zurich

SECA Evening Event 09.09.15, Widder Hotel, Zürich

Top 100 Swiss Startups 16.09.15, Hotel Royal Savoie, Lausanne

SECA Evening Event 14.10.15, Widder Hotel, Zürich

SECA Breakfast Event 06.11.15, Widder Hotel, Zürich

SECA Evening Event 18.11.15, Widder Hotel Zürich

More information will follow in due time. Please see also on www.seca.ch - Events.

Upcoming young SECA Events

10th Young SECA Get Together Event 21.05.15, Blue Monkey Zunftsaal zur Schneidern, Zürich

Young SECA Summer Event @ SUSI Partner Terrace 18.06.15, SUSI Partner, Zurich

14th Swiss Private Equity and Corporate Finance Conference, 08.07.15, SIX, Convention Point, Zurich

11th Young SECA Get Together 27.08.15, Tamedia, Zurich

12th Young SECA Get Together 12.11.15, Zurich

More information will follow in due time. Please see also on www.seca.ch - Events.

Forthcoming related Events

Go Beyond March events - Events Section - Training Section

49th Swiss Venture Day (with General Assembly) 17.03.15, SIX Swiss Exchange, Zurich

M&A-Seminar Transaktionserfahrung aus erster Hand 27.03.15, Radisson Blu Hotel, Zurich Airport

20th MedTech Investing Europe Conference 21./22.04.15, Lausanne

unquote Nordic Private Equity Forum 2015 05.05.15,Grand Hôtel, Stockholm

India Symposium 29.05.15, The Dolder Grand, Zurich

venture.ch Investor Day 15.06.15, ETH Zürich

Private equity training Zurich 14.07.15 Private Equity for Support Staff - An Introduction to Private Equity

Private equity training Zurich 15/16.07.15 Private Equity - Negotiation & Investment Structuring

50th Swiss Venture Day 09.09.15, SIX Swiss Exchange, Zurich

3rd CEO Day Dinner 20.10.15, BERNEXPO, Bern

12th CEO Day 21.10.15, Stade de Suisse, Bern

51st Swiss Venture Day 03.12.15, SIX Swiss Exchange, Zurich

Editor

SECA eNewsletter is a free online newsletter published by Maurice Pedergnana, Managing Director of the SECA Swiss Private Equity & Corporate Finance Association, received by more than 3'000 email addresses. More information: www.seca.ch or +41 41 757 67 77 (Andrea Villiger). The eNewsletter archive service is available only for SECA members.